The Pharma Data

JANUARY 12, 2021

Department of Health and Human Services (HHS) and the Department of Defense (DOD) will purchase additional supply of the casirivimab and imdevimab antibody cocktail for use in non-hospitalized COVID-19 patients to meet the federal government’s Operation Warp Speed goals. million doses. . We are pleased to work with the U.S.

Government 52

Government Hospitals Virus Production 52

Drug Discovery World

JUNE 9, 2023

The University of Queensland (UQ), Australia, and Emory University in Atlanta, US, have committed to scaling up their collaboration to focus on pandemic preparedness and regional disease prevention. This partnership will make Brisbane a centre for the Asia Pacific region and significant player of the burgeoning global biomedical industry.

Vaccine 130

Vaccine Clinical Trials Virus Government 130

The Pharma Data

MAY 22, 2023

WHO launches global network to detect and prevent infectious disease threats WHO and partners are launching a global network to help protect people from infectious disease threats through the power of pathogen genomics. New, more transmissible variants of the virus would not have been as quickly identified.

Disease 52

Disease Bioinformatics Virus Vaccine 52

PLOS: DNA Science

JULY 27, 2023

That information led, thanks to vaccine shelved from the first SARS circa 2003, to the rapid development and deployment of mRNA vaccines against the new infectious disease. The owners of the felines all reported feeding their pets raw meat, and samples of the meat revealed not only flu virus genetic material, but also infectious virus.

Disease 80

Disease DNA Virus RNA 80

Drug Discovery World

JANUARY 9, 2024

They include therapeutics for conditions including breast cancer, haemophilia A, sickle cell disease, Crohn’s disease, ulcerative colitis, respiratory syncytial virus (RSV) and multiple myeloma, among others. Due to a delayed US launch it remains a drug to watch for 2024.

Drugs 173

Drugs Therapies Treatment Virus 173

Codon

AUGUST 26, 2024

When COVID-19 emerged in 2019, by contrast, mRNA vaccines developed by Pfizer and Moderna took just 326 days from the initial sequencing of the virus to gaining approval for emergency use. These drugs would be ideal tools to bridge the wait for a vaccine against a quickly-spreading virus.

RNA 87

RNA Virus DNA Vaccine 87

The Pharma Data

JANUARY 6, 2021

A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures.’ The published study results showed that OYA1 was “highly effective” in reducing the spread of Ebola Virus infection in laboratory tests with the live Ebola virus carried out by NIAID.

Virus 40

Virus Clinical Trials Government Laboratories 40

The Pharma Data

DECEMBER 25, 2020

26, 2020 /CNW/ – The Government of Canada has a monitoring program in place with the provinces and territories to identify new COVID-19 variants in Canada , such as the ones identified in the United Kingdom and South Africa. OTTAWA, ON , Dec.

Virus 52

Virus Compliance Government Laboratories 52

The Pharma Data

SEPTEMBER 16, 2020

The government is facing criticism over its “world-beating” coronavirus testing system after people reported struggles to get tests, including being offered slots at testing centres a long way away. Image copyright. Getty Images. Matt Hancock: “The average distance travelled to a test site is now just 5.8 France processed 7.4m

Government 52

Government International Laboratories Hospitals 52

Drug Discovery World

JULY 30, 2024

Meanwhile, the transcriptome, the approximate 85% of the human genome that encodes RNA and has recently been shown 1 to be the site of the majority of human genetic variation that underlies disease, remains largely unexplored. MT: What types of conditions or diseases do you think will benefit most from RNA-targeting therapeutics?

Small Molecule 162

Small Molecule RNA Disease DNA 162

The Pharma Data

DECEMBER 16, 2020

Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced an Advance Purchase Agreement with the government of New Zealand for the purchase of 10.7 GAITHERSBURG, Md., 16, 2020 (GLOBE NEWSWIRE) — Novavax , Inc. About NVX-CoV2373.

Government 52

Government Vaccine Immune Response Clinical Trials 52

The Pharma Data

APRIL 14, 2021

government for its neutralizing antibody therapies authorized for emergency use as a treatment for COVID-19. government have agreed to modify the purchase agreement of bamlanivimab alone and focus on supply of bamlanivimab and etesevimab together. It was identified from a blood sample taken from one of the first U.S.

Government 52

Government Long-Term Care Facilities Hospitals Treatment 52

DrugBank

JULY 18, 2024

Vaccines have consistently demonstrated their efficacy in protecting people from infectious diseases. This led to the eradication of smallpox and polio – two debilitating diseases that historically caused global epidemics. Let’s take a deeper dive into these challenges.

Vaccine 79

Vaccine Immune Response Clinical Trials Virus 79

PLOS: DNA Science

AUGUST 22, 2024

It might seem minor, just a few pages, but the entire subplot of a nefarious government cover-up of a biotech disaster unfurls from it. Unforgettably, my daughter Heather threw up on the volcano, an early sign of gallbladder disease and to this day, her claim to fame. ” I can’t wait for the film.

DNA 52

DNA Virus Organic Chemistry Science 52

Broad Institute

SEPTEMBER 30, 2024

Today, about a third of Broad’s Terra users are from the public health workforce; in the US, 76 state and local public health labs use the platform for preventing and monitoring infectious disease spread in their communities. This was true in the US and all the more in the Global South, where the burden of infectious disease is the highest.

Bioinformatics 100

Bioinformatics Disease Engineering Virus 100

The Pharma Data

APRIL 26, 2022

NYSE: PFE) today reported positive Phase 2 pediatric data for their Lyme disease vaccine candidate, VLA15. About VLA15 VLA15 is the only Lyme disease vaccine candidate currently in clinical development. The medical need for vaccination against Lyme disease is steadily increasing as the geographic footprint of the disease widens7.

Vaccine 52

Vaccine Disease Protein Expression Trials 52

Drug Discovery World

JANUARY 21, 2024

Inspired by the overall event theme of ‘Innovation at Every Turn’, the DDW track will present leading research and case studies from experts in academia, government agencies and the industry on how technology is innovating from bench to bedside, lab to patient. It is sponsored by Integra Biosciences and Hamamatsu Corporation.

Vaccine 130

Vaccine Computational Chemistry Animal Testing Engineering 130

The Pharma Data

OCTOBER 28, 2020

This effort is part of a three-way agreement among Takeda, Moderna and the Government of Japan’s Ministry of Health Labour and Welfare (MHLW). Takeda is collaborating with the Japanese Government and vaccine developers to provide rapid and sustained access to COVID-19 vaccines in Japan,” said Rajeev Venkayya, M.D., is fully enrolled.

Government 40

Government Vaccine Pharmaceutical Companies Pharmaceuticals 40

The Pharma Data

NOVEMBER 6, 2020

universities reopened their campuses to students in some capacity this fall, the newspaper said, and some schools have appeared to keep the virus in check, primarily through extensive testing programs. More than a third of U.S. The coronavirus has been responsible for at least 80 deaths on college campuses this year. 15, the Post reported.

Virus 40

Virus Vaccine Government Doctors 40

The Pharma Data

JULY 21, 2021

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, and Pfizer Inc. About Lyme Disease. Juan Carlos Jaramillo M.D., About VLA15.

Vaccine 52

Vaccine Disease Trials Protein Expression 52

The Pharma Data

AUGUST 11, 2020

It has not received general approval to treat the virus in the US, but has in several European countries and Japan. The request for approval comes nearly two months after a study from the National Institute of Allergy and Infectious Diseases which showed positive results, with the drug effectively blocking the virus from replicating.

FDA Approval 52

FDA Approval FDA Government Virus 52

Drug Discovery World

FEBRUARY 6, 2024

Auransa, which harnesses available data to discover highly intractable diseases with poorly understood biology. Pharos iBio, which utilises AI technology to develop treatments for refractory and rare diseases such as cancers and repurpose existing therapies. Obulytix is not alone.

Marketing 173

Marketing Laboratories Engineering Clinical Trials 173

Common Sense for Drug Policy Blog

JANUARY 1, 2024

Cost-Effectiveness of Syringe Service and Needle Exchange Programs "The infectious disease consequences of injection drug use place a heavy toll on entire communities and are a serious threat to the health and well-being of our nation. 19 In 2019, HIV care and treatment cost the US government more than $20 billion.

Virus 40

Virus Government Hospitals Treatment 40

The Pharma Data

OCTOBER 28, 2020

In the overall patient group with detectable virus at baseline, the average daily reduction in viral load through day 7 was a 0.36 About REGN-COV2 REGN-COV2 is a combination of two monoclonal antibodies (REGN10933 and REGN10987) and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19.

Virus 40

Virus Trials Clinical Trials Production 40

The Pharma Data

SEPTEMBER 20, 2020

The UK is at a “critical point” in the coronavirus pandemic and “heading in the wrong direction”, the government’s chief medical officer will warn later. At the briefing later, Prof Whitty will be joined by the government’s chief scientific adviser Sir Patrick Vallance, to present the latest data.

Government 52

Government Virus Hospitals Disease 52

The Pharma Data

AUGUST 19, 2020

The UK government is not considering making the wearing of face masks compulsory in offices and workplaces, Health Secretary Matt Hancock has said. Previously, the French government only advised wearing masks at work when distancing is not possible. However, the government has set out guidance for particular industries.

Government 52

Government Virus Disease Research 52

The Pharma Data

FEBRUARY 24, 2022

Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today announced that Health Canada has granted approval for COVIFENZ®, COVID-19 vaccine, (plant-based virus-like particles [VLP], recombinant, adjuvanted). This vaccine is indicated for active immunization to prevent coronavirus disease 2019 (COVID?19)

Vaccine 52

Vaccine Virus Government Disease 52

The Pharma Data

SEPTEMBER 25, 2020

Dame Anne Johnson, a professor of infectious disease epidemiology at University College London, said it was essential to act quickly to stop the growth in the epidemic. It may be that reinforcing the need for people to limit their contacts with others will be enough to change the virus’s course. Stop the virus in its tracks?

Virus 52

Virus Government Doctors Hospitals 52

Eye on FDA

MARCH 30, 2022

First, government funding supporting access to vaccination and treatment for COVID has run out and so far, is not replenished. The government established program to fund access for the uninsured has stopped accepting reimbursement claims for treatment and will stop shortly for vaccines (on April 5). And there are consequences.

Vaccine 76

Vaccine Government FDA Virus 76

The Pharma Data

SEPTEMBER 19, 2020

Boris Johnson is spending the weekend considering whether to tighten Covid-19 measures in England, after saying the UK was “now seeing a second wave” The government is understood to be looking at a ban on households mixing, and reducing opening hours for pubs. At least 13.5 Further Covid-19 measures ‘likely’ in London.

Government 52

Government Virus Hospitals Science 52

The Pharma Data

AUGUST 16, 2021

The antiviral agent incorporates RNA-like building blocks into the RNA genome of the virus. Since the onset of the corona pandemic, numerous scientific projects set out to investigate measures against the new virus. ” Mutations in the genome stop the virus. government is already optimistic and has recently secured about 1.7

RNA 52

RNA Virus Clinical Trials Drugs 52

The Pharma Data

SEPTEMBER 30, 2020

They said the R number, the virus’s reproduction number, appears to have fallen since measures including the “rule of six” were introduced. The React study is highly influential, both due to its size and because it gives an up-to-date picture of how the virus is spreading. Image copyright. Image caption.

Virus 52

Virus Government Hospitals Research 52

The Pharma Data

SEPTEMBER 18, 2020

Local restrictions do not suppress a virus that is spreading outside of those areas. It is against this backdrop the government is deciding what to do next. That is not sophisticated disease modelling, it is not written in stone and measures such as the “rule of six” should slow the spread.

Virus 52

Virus Government Vaccine Hospitals 52

The Pharma Data

JULY 23, 2021

In December 2020, Chugai obtained development and exclusive commercialisation rights in Japan from Roche, and is working with the Japanese government to ensure an appropriate and timely supply of Ronapreve. We also continue to identify, develop and support potential therapies which can play a role in treating the disease.

Treatment 52

Treatment Virus Clinical Trials Government 52

The Pharma Data

DECEMBER 22, 2020

Three Northwestern experts — Lorenzo-Redondo, a research assistant professor in infectious diseases; Dr. Michael Ison, a professor of infectious diseases; and Dr. Marc Sala, an assistant professor of pulmonary and critical care — answer some key questions people might have about the new variant. ” What is a variant?

Virus 52

Virus Vaccine Immune Response Treatment 52

The Pharma Data

SEPTEMBER 10, 2020

No virus would mean a free pass to mix freely with other people without the need for social distancing. In leaked UK government plans , mass testing is described as “top priority” But Mr Johnson acknowledged it was “an ambitious agenda” So what do scientists think? But tests are rarely 100% accurate.

Virus 52

Virus Government Laboratories Disease 52

The Pharma Data

NOVEMBER 12, 2021

EU marketing authorisation follows approvals in Japan, the United Kingdom and Australia Approval based on data demonstrating Ronapreve reduced risk of hospitalisation in certain patients with mild to moderate disease and reduced risk of symptomatic COVID-19 infections in people exposed to the virus.

Disease 40

Disease Government Treatment Clinical Trials 40